|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 31 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-13 |
4 |
OE |
$67.81 |
$406,860 |
D/D |
6,000 |
326,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-10 |
4 |
OE |
$67.81 |
$1,017,150 |
D/D |
15,000 |
502,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-13 |
4 |
OE |
$67.81 |
$542,480 |
D/D |
8,000 |
495,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-04-06 |
4 |
OE |
$67.81 |
$678,100 |
D/D |
10,000 |
435,896 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-04-10 |
4 |
OE |
$67.81 |
$678,100 |
D/D |
10,000 |
435,896 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-09 |
4 |
OE |
$67.81 |
$2,034,300 |
D/D |
30,000 |
456,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-10 |
4 |
OE |
$67.81 |
$2,034,300 |
D/D |
30,000 |
456,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-11 |
4 |
OE |
$67.81 |
$2,034,300 |
D/D |
30,000 |
456,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-12 |
4 |
OE |
$67.81 |
$3,153,165 |
D/D |
46,500 |
472,713 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2023-12-21 |
4 |
OE |
$63.10 |
$631,000 |
D/D |
10,000 |
435,112 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-09 |
4 |
OE |
$63.10 |
$631,000 |
D/D |
10,000 |
435,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-10 |
4 |
OE |
$63.10 |
$631,000 |
D/D |
10,000 |
435,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-08 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
434,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-09 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
434,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-11 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-12 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-09 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-10 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-10 |
4 |
S |
$20.20 |
$724,917 |
D/D |
(35,886) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-17 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-02-29 |
4 |
S |
$37.91 |
$805,798 |
D/D |
(21,142) |
4,071 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-03 |
4 |
S |
$38.10 |
$76,239 |
D/D |
(2,000) |
11,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-04 |
4 |
S |
$38.00 |
$152,000 |
D/D |
(4,000) |
7,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-09 |
4 |
S |
$38.39 |
$310,031 |
D/D |
(8,000) |
8,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-12 |
4 |
S |
$39.15 |
$195,791 |
D/D |
(5,000) |
3,567 |
0 |
- |
|
850 Records found
|
|
Page 31 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|